<?xml version="1.0" encoding="UTF-8"?>
<p id="par0200">Considering multiple clinical and histological parameters, two main different results were obtained when the CCR5Δ32 genetic variant was evaluated in the context of HCV-related diseases: reduced liver inflammation in Δ32 allele carriers (
 <xref rid="bib0625" ref-type="bibr">Hellier et al., 2003</xref>; 
 <xref rid="bib1590" ref-type="bibr">Wald et al., 2004</xref>; 
 <xref rid="bib0545" ref-type="bibr">Goulding et al., 2005</xref>); and no association between the CCR5Δ32 and clinical variables (
 <xref rid="bib0510" ref-type="bibr">Glas et al., 2003</xref>; 
 <xref rid="bib0970" ref-type="bibr">Mangia et al., 2003</xref>; 
 <xref rid="bib1175" ref-type="bibr">Promrat et al., 2003</xref>; 
 <xref rid="bib0555" ref-type="bibr">Goyal et al., 2006</xref>; 
 <xref rid="bib0995" ref-type="bibr">Mascheretti et al., 2004</xref>; 
 <xref rid="bib1240" ref-type="bibr">Ruiz-Ferrer et al., 2004</xref>; 
 <xref rid="bib1030" ref-type="bibr">Morard et al., 2014</xref>; 
 <xref rid="bib0410" ref-type="bibr">Ellwanger et al., 2018b</xref>).
</p>
